Mahsa Yarelahi; Elham Rezaian; Farzaneh Bahadori; Zeinab Sahraian; Somayeh Abolghsemi; Masoud Karimi
Abstract
Background: The success of the vaccination programs against covid-19 depends on the level of community vaccine acceptance. The present study aimed to investigate the predictors of older adults’ intention to uptake the covid-19 vaccine in older adults.Methods: This cross-sectional study was conducted ...
Read More
Background: The success of the vaccination programs against covid-19 depends on the level of community vaccine acceptance. The present study aimed to investigate the predictors of older adults’ intention to uptake the covid-19 vaccine in older adults.Methods: This cross-sectional study was conducted on 345 older adults in Jahrom, southern Iran. Participants were enrolled by stratified random sampling. The data collection tool was a researcher-made questionnaire consisting of items based on the health belief model (HBM), Theory of planned behavior (TPB) constructs and demographic information. Descriptive statistics, Spearman’s correlation, and Ordinal logistic regression analysis were used for data analysis using SPSS version 25. The level of significance was set at 0. 05.Results: The mean age of participants was 67.7 (7.2) years. Most of the participants (51.3%) intended to receive the vaccine. Perceived barriers (r=-0.201), perceived benefits (r=0.302), selfefficacy (r=0.269), and subjective norms (r=0.387) had significant associations with the intention to vaccine (P<0.001). Subjective norms (β=0.159, P<0.001) were the most powerful predictor of intention to vaccine, followed by perceived benefits (β=0.112, P=0.035) and self-efficacy (β=0.086, P=0.038).Conclusion: health professionals should promote positive attitudes toward the covid-19 vaccine and reports about vaccination by celebrities and trusted people to persuade older adults to receive the covid-19 vaccine.
Rozhan Khezri; Saeed Golfiroozi; Hossein- Ali Nikbakht; Zahra Maleki; Mousa Ghelichi- Ghojogh
Abstract
This article has no abstract.
Read More
This article has no abstract.
Asita Elengoe; Shalini Selvam
Abstract
Background: The year 2020 began with a new public health hazard. A novel coronavirus, acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered in Wuhan, China on 12th December 2019. In 2020, the World Health Organization (WHO) introduced the name of the disease as ‘COVID-19’. ...
Read More
Background: The year 2020 began with a new public health hazard. A novel coronavirus, acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered in Wuhan, China on 12th December 2019. In 2020, the World Health Organization (WHO) introduced the name of the disease as ‘COVID-19’. Objective: The morphology, pathogenic mechanisms, causes, transmission, symptoms, diagnosis, therapeutic potential, clinical studies on COVID-19 infection, preventive measures, and mental health care were described in this study. Methods: A literature search was conducted using electronic databases such as PubMed, Scopus, Elsevier, Frontiers, Medline, EMBASE, Web of Science, Science Direct, and Google Scholar. The search was broadly scoped, using key terms such as SARS-CoV-2, COVID-19, etc. Results: The genomic characterization of SARS-CoV-2, drugs, and their potential mechanisms used in humans to inhibit the SARS-CoV-2 were tabulated. Moreover, twenty-five clinical researches carried out against COVID-19 infection were also tabulated in this study. Preventive measures such as chemical disinfectants and increasing test capacity were also discussed. Conclusion: The current study provides a snapshot of the overview of the SARS-CoV-2 and COVID-19. The findings suggested the effective preventive measures to halt the spread of SARS-CoV-2 and develop a better vaccine. The information from this review study also aids in early preparations for future pandemic outbreaks.
